Home › Ulcerative Colitis › Minnesota
Ulcerative Colitis clinical trials in Minnesota
8 studies for Ulcerative Colitis are looking for participants at sites in Minnesota.
Cities in Minnesota
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 028, Rochester
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 29, 2026 · NCT07012395A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Mayo Clinic in Rochester, Minnesota, Rochester
RecruitingPhase 2/3
Ages 2 to 17 · All sexes · Updated Sep 24, 2026 · NCT05076175LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Mayo Clinic in Rochester, Minnesota, Rochester
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 22, 2026 · NCT07415044A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- MNGI Digestive Health, PA, Plymouth
RecruitingPhase 4
Ages 18 to 65 · All sexes · Updated Sep 21, 2026 · NCT06095128Microbiome-targeted Diet Therapy in Ulcerative Colitis
- University Of Minnesota, Minneapolis
Recruiting
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07520461BOOM-IBD2 Pivotal Clinical Trial
- MN Urology, Woodbury
Recruiting
Ages 18 to 85 · All sexes · Updated Aug 6, 2026 · NCT06571669R-3750 in Patients With Mild to Moderate Ulcerative Colitis
- Mayo Clinic, Rochester
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Jun 12, 2026 · NCT05666960Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
- Mayo Clinic, Rochester
Recruiting
Ages 18 to 85 · All sexes · Updated Jan 8, 2026 · NCT05987852From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.